Jane Lebkowski is SVP & Chief Scientific Officer at GERON CORP (GERN). They have made 9 open-market trades across 1 company since 2006, most recently 2017-06-05.
CIK 0001187035
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AST | SELL · 10b5-1 | 2015-09-15 | 2015-09-16 | $6.00 | $29K | -32.5% | -2.1% | -2.1% |
| GERN | SELL | 2011-06-14 | 2011-06-16 | $4.28 | $108K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2011-05-24 | 2011-05-24 | $4.47 | $13K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2010-06-02 | 2010-06-03 | $5.43 | $58K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2010-05-24 | 2010-05-25 | $5.11 | $12K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2009-05-29 | 2009-06-01 | $6.35 | $14K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2009-05-26 | 2009-05-28 | $6.75 | $95K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2009-01-05 | 2009-01-06 | $4.90 | $43K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2008-01-04 | 2008-01-04 | $5.34 | $48K | -30.2% | -1.9% | -1.9% |
| GERN | SELL | 2006-01-09 | 2006-01-10 | $8.56 | $91K | -30.2% | -1.9% | -1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.